Designing vaccines based on biology of human dendritic cell subsets
about
Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineagesDendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic ToolsThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityRegulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic PotentialsPrimer on tumor immunology and cancer immunotherapyDendritic cells: arbiters of immunity and immunological tolerancePros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesImmune evasion pathways and the design of dendritic cell-based cancer vaccinesDendritic cell-based vaccine efficacy: aiming for hot spotsRole of fatty-acid synthesis in dendritic cell generation and functionSelf-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In VivoCancer immunotherapy comes of ageA novel method for synthetic vaccine construction based on protein assemblyDefining epitope coverage requirements for T cell-based HIV vaccines: theoretical considerations and practical applications.Controlling the HIV/AIDS epidemic: current status and global challengesDendritic cell-associated miRNAs are modulated via chromatin remodeling in response to different environments.The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.Intracellular bacteria interfere with dendritic cell functions: role of the type I interferon pathway.Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly.CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphomaProduction of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines.Generation of more effective cancer vaccinesMurine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.Reconstituted high-density lipoprotein modulates activation of human leukocytes.Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer.Classification of current anticancer immunotherapiesSkin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.The human condition: an immunological perspective.Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.Dendritic cell dysfunction during primary HIV-1 infection.HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivoImmunosenescence and Challenges of Vaccination against Influenza in the Aging Population.Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.
P2860
Q24617939-BD522DF8-7643-4114-9F5F-699975940E94Q26749296-F53EB3C2-ABF6-4DED-B010-34C06403DAC1Q26785900-31A7F39B-78B5-4926-99E5-041D41AD6CF4Q26797333-3F73DB58-7ABC-4FAD-B5B0-2B023122C1F6Q27001126-26E956D7-4575-4E90-AE90-EF73873B4026Q27001626-DE1497FB-A641-4A1B-A4BC-51CBB4F0D28BQ27013679-7158F9C3-EECB-4944-9E20-9C86A759D52BQ28076556-96797F55-0C94-474E-A8D7-BAB630B1CD82Q28082680-FB137386-6CF4-4455-8158-2E1AC1ED5663Q28397185-DE6A3D0A-E240-4C2A-A006-2FEB7CC865D2Q28654968-DF6B5D28-FB3B-41C7-9751-410CDFCEE837Q29619918-E9DBAA6E-DE37-4EA1-B3A2-AF541C99A2D9Q30369012-CD2E5ADB-F4F0-4275-ACFF-EC671BC4DF6AQ30410411-044DE6B0-06DC-46C6-8178-DBC7FF56342EQ30420558-1FBB4558-BB01-4546-9937-05C118452F2FQ31155451-CD9D3A87-3635-4CE4-B4E8-CE2B958F7690Q33662836-EEF6BF44-60B9-4B18-B085-36C4AA84A329Q33689478-2672CFE1-4BB3-4F89-9DF8-AF2F553AB4A3Q33734122-FAF019FF-8C15-465D-B283-6CCC65C78006Q33899392-3DE55C07-6EB1-4DDD-B317-A299578D94B5Q34014497-48DCA805-DAAE-493B-927A-6F1E4727EAFCQ34033774-3C829AF9-6960-48E5-AA3C-1B0232C31707Q34169981-596974EC-299E-4872-92BA-8A08DF417C0FQ34342500-70DDC6BD-07FA-490E-A5DA-802AEF10FC62Q34584142-E32C931C-A494-4582-BE4A-6EE21BCD1EFAQ34963571-3631FF0C-23F2-4EBA-AFF7-E4A9C14D2E62Q35122841-FA7DDE7E-8955-4527-B6AE-DCBFC74703EAQ35138155-13316AB6-025D-4DC3-A1D9-92AC88605419Q35144659-1DEBF313-7B95-4FB3-A268-170E36709833Q35149637-0C9093EF-3480-4CBE-929F-381696D1282CQ35184456-8B70CFC8-EB1C-4138-A073-8B5B75A59CF4Q35188878-57173DB2-774D-42B0-BCD7-1AFBEF00073EQ35192675-A0E2860C-BCC4-4ED9-B606-311B58BB590CQ35331473-861E909D-6A7C-461E-8A40-FE1A8F2D95A5Q35556207-E0672F59-05CE-4BFC-A982-747E90A0CCA3Q35686234-D9020907-DABF-49CB-A35B-84C93C528398Q35874111-ACFF9748-E20B-414A-B513-907CA7CE4C9FQ35887679-CA7ABDBC-1809-4294-AD74-BF9B0DBA6545Q35943471-8581DFF4-D0AE-42C3-92C3-05010C342375Q36014997-220C544A-7C11-4823-9E2F-605C1FBF6D4A
P2860
Designing vaccines based on biology of human dendritic cell subsets
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Designing vaccines based on biology of human dendritic cell subsets
@ast
Designing vaccines based on biology of human dendritic cell subsets
@en
Designing vaccines based on biology of human dendritic cell subsets
@nl
type
label
Designing vaccines based on biology of human dendritic cell subsets
@ast
Designing vaccines based on biology of human dendritic cell subsets
@en
Designing vaccines based on biology of human dendritic cell subsets
@nl
prefLabel
Designing vaccines based on biology of human dendritic cell subsets
@ast
Designing vaccines based on biology of human dendritic cell subsets
@en
Designing vaccines based on biology of human dendritic cell subsets
@nl
P2860
P1433
P1476
Designing vaccines based on biology of human dendritic cell subsets
@en
P2093
Ira Mellman
Karolina Palucka
P2860
P304
P356
10.1016/J.IMMUNI.2010.10.007
P407
P577
2010-10-01T00:00:00Z